Volume 50, Issue 3 pp. 314-321
Original Study

Hemodynamic effects of iodixanol and iohexol during ventriculography in patients with compromised left ventricular function

Arend Bergstra BSC

Corresponding Author

Arend Bergstra BSC

Department of Cardiology/Thoraxcenter, Groningen University Hospital, Groningen, The Netherlands

Department of Cardiology/Thoraxcenter, University Hospital Groningen, PO Box 30.001, 9700 RB Groningen, The NetherlandsSearch for more papers by this author
René B. van Dijk MD, PhD

René B. van Dijk MD, PhD

Department of Cardiology, Martini Hospital, Groningen, The Netherlands

Search for more papers by this author
Oddmund Brekke MSC

Oddmund Brekke MSC

Clinical R&D, Nycomed Imaging, Oslo, Norway

Search for more papers by this author
Arie E. Buurma BSC

Arie E. Buurma BSC

Department of Cardiology/Thoraxcenter, Groningen University Hospital, Groningen, The Netherlands

Search for more papers by this author
Leandro Orozco MD

Leandro Orozco MD

Clinical R&D, Nycomed Imaging, Oslo, Norway

Search for more papers by this author
Peter den Heijer MD, PhD

Peter den Heijer MD, PhD

Department of Cardiology, Ignatius Hospital, Breda, The Netherlands

Search for more papers by this author
Harry J.G.M. Crijns MD, PhD

Harry J.G.M. Crijns MD, PhD

Department of Cardiology/Thoraxcenter, Groningen University Hospital, Groningen, The Netherlands

Search for more papers by this author

Abstract

A crossover study was performed to compare the hemodynamic effects of the iso-osmolar contrast agent iodixanol (Visipaque®) 320 mg I/ml to those of the low-osmolar iohexol (Omnipaque®) 350 mg I/ml. The main hypothesis was that iodixanol and iohexol would affect left ventricular end-diastolic pressure (LVEDP) to different degrees. In 48 patients with reduced cardiac function (mean ejection fraction 33.4%), one ventricular injection was performed with each contrast medium. Ventricular, aortic and right atrial pressures and heart rate were measured continuously. Cardiac output (using Fick's principle) and systemic vascular resistance were calculated. LVEDP increased with both agents, but significantly less after iodixanol than after iohexol (P < 0.01), also in subgroups of patients in whom baseline LVEDP was severely increased and in whom 3-vessel disease was present. Immediate changes in variables reflecting vasodilatation were similar with both agents. In conclusion, both contrast agents influenced hemodynamics during ventriculography, but iodixanol had significantly less influence on LVEDP than did iohexol. Cathet. Cardiovasc. Intervent. 50:314–321, 2000. © 2000 Wiley-Liss, Inc.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.